Navigation Links
Generic drug costs remain shackled

Price controls for generic drugs in primary care are likely to remain unchanged for the next year as the european government considers how best to supply the NHS. In 1999, a severe shortage of non-brand name medicines resulted in a 12.5 per cent increase in the cost of prescription drugs for the NHS, significantly higher than the 8 per cent average increase in previous years. //

Pharmaceutical companies were accused of holding the NHS to ransom, and to protect the service from spiralling high prices the government began a maximum price scheme in August 2000. The measures had saved the NHS about £240 million during 2000 and 2001, and restored stability to the generics market. Under the European Directive the scheme must be reviewed within 12 months of its implementation.

The maximum price scheme would remain in force until a decision had been made on how best to supply generic medicines cost-effectively to the NHS. A spokesperson for the British Generic Manufacturers Association said the extension raised a number of issues. Continuing to base the controls on 1998 prices was likely to be painful, especially as a number of important products would be coming off patent next year. Department of Health figures show that last year 52 per cent of all dispensed prescriptions were for generic medicines.


'"/>




Page: 1

Related medicine news :

1. FDA Approves Indian Generic Drug For AIDS Treatment
2. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
3. AIDS Generic Drugs Approved by FDA for Sale in US
4. HIV Mortality declining in India due to Generic Antiretroviral therapy drugs
5. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
6. Generic Products Compete With GlaxoSmithKline
7. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
8. Ranbaxy Expands By Acquiring A Generic Company In Belgium
9. First Generic Version of Lexapro permitted by US
10. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
11. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Generic drug costs remain shackled

(Date:9/17/2014)... N.J. (PRWEB) September 17, 2014 ... advanced delivery technologies and development solutions for drugs, ... launch of OptiPact™, an integrated service and technology ... compaction, and provided from the company’s 450,000 sq. ... describes Catalent’s ability to integrate optimal formulation, development, ...
(Date:9/17/2014)... Positive messages about the health benefits of quitting smoking ... study suggests. Although smokers who think quitting will ... harmful effects of smoking, researchers found smokers who believe ... "gain-framed," or positive, messages about how quitting will improve ... mix of both types of messages might get more ...
(Date:9/17/2014)... New York (PRWEB) September 17, 2014 ... involving the Conserve line of metal-on-metal hip replacements ... underway in U.S. District Court, Northern District of ... updated Case List issued by the U.S. Judicial ... at least 397 product liability claims have been ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Smart Flour ... Picks by Progressive Grocer, a leading trade magazine targeted ... awarded for originality and flavor, among other attributes. Smart ... an Editor’s Pick in the September print issue of ... website. , The pizza won based on its superior ...
(Date:9/17/2014)... GA (PRWEB) September 17, 2014 Leading ... to announce the launch of its new vegan and ... is extremely effective and provided the results skincare testers ... to create a gentle yet active mask that provided ... Lake Louise.” , This Sugar Cane Fruit Mask combines ...
Breaking Medicine News(10 mins):Health News:New OptiPact™ Technology Introduced by Catalent 2Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2Health News:EcoBeauty Brand Lotus Moon Unveils New Gluten-Free Sugar Cane Fruit Mask 2
... Month, BETHESDA, Md., Jan. 3 AABB (formerly ... individuals,participating in the presidential elections to continue making an ... the month of,January, National Blood Donor Month (NBDM) provides ... give blood at a time of the year when,it ...
... ... Refractory Patients to Replace Current TIME-2 ... Trial ... Kosan Biosciences,Incorporated (Nasdaq: KOSN ) today announced that the Tanespimycin in,Myeloma Evaluation or TIME-1 pivotal Phase ...
... young people,s blood sugar levels, study finds , THURSDAY, Jan. ... three nights running has the same negative effect on the ... pounds, diabetes researchers report. , In fact, young adults ... their risk of type 2 diabetes, according to a study ...
... others with a family history of ... glaucoma are particularly vulnerable, SAN FRANCISCO, Jan. 3 ... do not notice as their peripheral,vision diminishes or blind spots occur. ... disease are unaware of their condition.,January is Glaucoma Awareness Month, and ...
... Abbott (NYSE: ABT ),will announce its financial results ... on Wednesday, Jan. 23, 2008, before the market opens., ... webcast of the earnings,conference call at 8 a.m. Central ... Investor Relations Web site at, http://www.abbottinvestor.com . An archived ...
... the story is the same: New,Year,s resolutions made, New ... be combined with online health tools and expert advice,to ... growing health,properties on the Internet -- launched "Resolutions 2.0," ... video from Revolution Health at:, http://media.medialink.com/WebNR.aspx?story=34279 ) "Resolutions ...
Cached Medicine News:Health News:Exercise Your Right to Vote and Continue to Make a Difference by Giving Blood in 2008 2Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 2Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 3Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 4Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 5Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 6Health News:Lack of Deep Sleep Raises Diabetes Risk 2Health News:Lack of Deep Sleep Raises Diabetes Risk 3Health News:Knowing Your Risks Can Stop the Sneak Thief of Sight 2Health News:Knowing Your Risks Can Stop the Sneak Thief of Sight 3Health News:VIDEO from Medialink and Revolution Health: RevolutionHealth.com Launches 'Resolutions 2.0' 2
(Date:9/17/2014)... Sept. 17, 2014   OTEMR, Inc. , ONETOUCH ... EHR certification, which designates that the software is capable ... and Stage 2 Meaningful Use measures required to qualify ... (ARRA).  ONETOUCH EMR 2.0 was certified on July 14, ... the National Coordinator-Authorized Certification Body (ONC-ACB) and is compliant ...
(Date:9/17/2014)... , Sept. 17, 2014  Millions of people suffer from ... disease. Recently the FDA approved the launch ... an innovative implant device developed by Spinal Kinetics, which may ... neck and or arm pain. Hospital for Special Surgery (HSS), ... only hospital in New York City ...
(Date:9/17/2014)... Calif. , Sept. 17, 2014   ... data analytics solution that brings complete visibility to ... risks in an ever-evolving reimbursement landscape. Powered by ... brings transparency to the critical point between patient ... impact revenue. The solution will improve revenue capture, ...
Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3
... SPRING, Md., Nov. 23, 2011 The FDA today ... owner for substituting ingredients and products without noting the ... filed on behalf of the FDA by the U.S. ... and distributing more than 400 products for being in ...
... 23, 2011 /PRNewswire-iReach/ -- Now in its 13th ... discuss, investigate, and learn about the latest in pharmaceutical technology. ... at the Crocus Expo, International Exhibition Centre, in Moscow. ... sustainable air filters — a key ...
Cached Medicine Technology:FDA Takes Enforcement Action Against Pennsylvania Dietary Supplement Maker 2FDA Takes Enforcement Action Against Pennsylvania Dietary Supplement Maker 3Camfil Farr to Discuss Sustainable Air Filtration at PHARMTECH 2011 2Camfil Farr to Discuss Sustainable Air Filtration at PHARMTECH 2011 3
... 200 series offers a range of ... The design delivers therapy to meet ... promote results in commercial and clinical ... differentiator in the SleepStyle 200 series ...
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
The S7 Lightweight offers the comfort and reliability of the award-winning S7 series in a convenient, affordable device....
Medicine Products: